Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
No. 6 Dongting 3rd Street
Tianjin,
China
Phone
+86 22 6625 2888
Website
Sector
Healthcare
Industry
Biotechnology
Employees
9595
First IPO Date
December 10, 2021
| Name | Title | Pay | Year Born |
| Rui Yang | Co-CEO & Executive Director | 6.38M | 1977 |
| Hao Hong | Founder, Chairman & Chief Executive Officer | 8.51M | 1956 |
| Liang Hong | Executive Vice President & Executive Director | 3.57M | 1974 |
| Da Zhang | Chief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director | 5.87M | 1981 |
| Pingzhong Huang | Senior Vice President of Business Development & Project Management | 0 | N/A |
| Guoxi Zheng | Senior Vice President of EHS & UK Site Coordinator | 0 | N/A |
| Jiang Yingwei | Executive Vice President of Human Resources & Administration | 0 | 1977 |
| Yan Zhou | Senior Vice President of Quality Management | 0 | 1979 |
| Changhai Tian | Senior Vice President of 5S Management | 0 | N/A |
| Chaoyong Chen | Executive Vice President of Manufacturing & Tech Transfer | 0 | 1982 |
| Ching Kit Cheng | Joint Company Secretary | 0 | 1989 |
| Xiangke Xu | Senior Vice President and Board Secretary of Public Affairs & Regulatory Affairs & Legal Affairs | 0 | 1979 |
| Elut Hsu | Senior Vice President of U.S. Headquarters Operations & Business Development | 0 | N/A |
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.